Fund Iv L.P. Omega's Net Worth
Fund Iv L.P. Omega's net worth is estimated to be at least $14,182,082.02 as of 12/23/2024. CoreStreet's estimation of Fund Iv L.P. Omega's net worth is based on their sale of stock and current holding of stock.
Fund Iv L.P. Omega is Major Shareholder at Replimune Group Inc. They have executed at least 15 trades of stock as per SEC Form 4 filings. Their most recent trade was for 16,500 units of REPL stock on 03/14/2022. Their biggest sale was on 01/26/2021 when they sold 30,350 units of Replimune Group Inc stock for $1,378,497.00. They typically trade 3 times per year.
Total value of insider buys:
- $8,994,194.00
Total value of insider sells:
- $5,187,888.02
Most recent insider trade:
- March 14, 2022
Fund Iv L.P. Omega's Insider Trading History
| Replimune Group Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 14, 2022 | Major Shareholder | 16,500 | $15.42 | Sell | $254,430.00 |
Nov. 22, 2021 | Director | 10,162 | $34.70 | Sell | $352,621.40 |
Nov. 18, 2021 | Director | 2,441 | $33.50 | Sell | $81,773.50 |
Nov. 15, 2021 | Director | 782 | $33.66 | Sell | $26,322.12 |
Nov. 12, 2021 | Director | 23,235 | $33.66 | Sell | $782,090.10 |
Nov. 10, 2021 | Director | 11 | $33.50 | Sell | $368.50 |
Nov. 8, 2021 | Director | 3,817 | $33.53 | Sell | $127,984.01 |
Nov. 4, 2021 | Director | 25,225 | $33.58 | Sell | $847,055.50 |
Sept. 23, 2021 | Director | 12,171 | $33.58 | Sell | $408,702.18 |
Sept. 16, 2021 | Director | 5,537 | $32.55 | Sell | $180,229.35 |
Feb. 8, 2021 | Major Shareholder | 5,249 | $45.00 | Sell | $236,205.00 |
Jan. 26, 2021 | Director | 30,350 | $45.42 | Sell | $1,378,497.00 |
Jan. 22, 2021 | Director | 11,359 | $45.04 | Sell | $511,609.36 |
Nov. 18, 2019 | Major Shareholder | 220,000 | $13.61 | Buy | $2,994,200.00 |
| Paratek Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 27, 2016 | Major Shareholder | 461,538 | $13.00 | Buy | $5,999,994.00 |